High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype

Authors :: De Groen, Ruben A.L.
Van Eijk, Ronald
van Wezel, Tom
Raghoo, Richard
Schrader, Anne-Roos
Jansen, Patty M.
briaire-De Bruijn, Inge
Kleiverda, Karin
Vlasveld, Tom
Terpstra, Valeska
Levenga, Henriette
Nicolae, Aline
Posthuma, Ward
Focke-Snieders, Isabelle
Hardi, Lizan
den Hartog, Wietske
Van Den Berg, Anke
Diepstra, Arjan
Lugtenburg, Pieternella
Kersten, Marie José
Pals, Steven T
Veelken, Hendrik
Bovée, Judith
Cleven, Arjen
Vermaat, Joost
Source :: Blood; November 2019, Vol. 134 Issue: Supplement 1 p1484-1484, 1p
Publication Year :: 2019
Abstract: Lugtenburg: Genmab: Consultancy, Honoraria; Servier: Consultancy, Honoraria, Research Funding; Roche: Consultancy, Honoraria, Research Funding, Speakers Bureau; BMS: Consultancy; Celgene: Consultancy, Honoraria; Janssen Cilag: Honoraria; Takeda: Consultancy, Honoraria, Research Funding. Kersten:Gilead: Honoraria; Mundipharma: Honoraria, Research Funding; Roche: Honoraria, Research Funding; Celgene: Honoraria, Research Funding; Amgen: Honoraria, Research Funding; Takeda Oncology: Research Funding; Miltenyi: Honoraria; Kite Pharma: Honoraria, Research Funding; Bristol-Myers Squibb: Honoraria, Research Funding; Novartis: Honoraria.

Full Text Access

Tools